Analyst Reco. MacroGenics, Inc.

Equities

MGNX

US5560991094

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
4.09 ^USD	-3.54%		-10.11%	-57.48%

May. 10	Sector Update: Health Care Stocks Higher Late Afternoon	MT
May. 10	Sector Update: Health Care	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BMO Downgrades MacroGenics to Market Perform From Outperform, Price Target at $8	May. 10	MT
Stifel Downgrades MacroGenics to Hold	May. 10	MT
TD Cowen Downgrades MacroGenics to Hold From Buy	May. 10	MT
B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target	Apr. 26	MT
TD Cowen Upgrades MacroGenics to Buy From Hold	Apr. 09	MT
JMP Securities Adjusts Price Target on MacroGenics to $22 From $16, Maintains Market Outperform Rating	Mar. 11	MT
HC Wainwright Adjusts Price Target on MacroGenics to $16 From $14, Maintains Neutral Rating	Mar. 11	MT
Stifel Adjusts Price Target on MacroGenics to $29 From $17, Keeps Buy Rating	Mar. 08	MT
BMO Capital Adjusts Price Target on MacroGenics to $24 From $18, Maintains Outperform Rating	Mar. 08	MT
BTIG Adjusts Price Target on MacroGenics to $24 From $12, Maintains Buy Rating	Mar. 04	MT
Barclays Raises Price Target on MacroGenics to $23 From $12, Maintains Overweight Rating	Feb. 29	MT
HC Wainwright Downgrades MacroGenics to Neutral From Buy, Adjusts Price Target to $14 From $12	Feb. 14	MT
JMP Securities Adjusts MacroGenics' Price Target to $16 From $10, Maintains Market Outperform Rating	Jan. 24	MT
Citigroup Upgrades MacroGenics to Buy From Neutral, Raises Price Target to $13 From $7	Dec. 20	MT
HC Wainwright Cuts MacroGenics' Price Target to $12 From $14, Keeps Buy Rating	Nov. 13	MT
Guggenheim Upgrades MacroGenics to Buy From Neutral, Price Target is $12	Nov. 07	MT
JMP Securities Adjusts Price Target on MacroGenics to $10 From $8, Maintains Market Outperform Rating	23-05-11	MT
BTIG Adjusts Price Target on MacroGenics to $12 From $6, Maintains Buy Rating	23-03-21	MT
HC Wainwright Adjusts MacroGenics Price Target to $14 From $12, Maintains Buy Rating	23-03-20	MT
Guggenheim Downgrades MacroGenics to Neutral From Buy	23-03-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. MacroGenics, Inc.

Equities

MGNX

US5560991094

Analyst Reco.

Filters